ウイルスと多発性硬化症

Same author

[Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia].

Neurologia·2020

Same author

Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries.

European journal of neurology·2018

Same author

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

The New England journal of medicine·2013

Same author

Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Same author

Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands.

Oral diseases·2010

Same author

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Same journal

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

JAMA·2026

Same journal

Surgical and Endoscopic Therapies for GERD.

JAMA·2026

Same journal

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026

Same journal

"Suturing": Love, Death, and Perfection's Limits.

JAMA·2026

Same journal

What Is Low Back Pain?

JAMA·2026

Same journal

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

JAMA·2026

関連する実験動画

ウイルスと多発性硬化症

関連する概念動画

[Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia].

Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries.

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma.

Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands.

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

Surgical and Endoscopic Therapies for GERD.

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

"Suturing": Love, Death, and Perfection's Limits.

What Is Low Back Pain?

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

関連する実験動画

ウイルスと多発性硬化症

関連する概念動画

関連記事

[Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia].

Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries.

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma.

Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands.

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.

Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

Surgical and Endoscopic Therapies for GERD.

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

"Suturing": Love, Death, and Perfection's Limits.

What Is Low Back Pain?

From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.